J Neurocrit Care.  2021 Jun;14(1):1-7. 10.18700/jnc.210007.

Role of continuous hypertonic saline in acute ischemic infarcts: a systematic literature review

• Chugh AJS
• Maynard M
• Sunshine K
• Shammassian BH
• Sauer A
• Odetoyinbo K
• Hoffer SA

• KMID: 2517127
• DOI: http://doi.org/10.18700/jnc.210007

Abstract

Continuous hypertonic saline for hemispheric ischemic infarcts has been routinely used in neurocritical centers for the management of malignant cerebral edema. However, the data supporting its use are extremely limited. We present a systematic literature review that highlights five studies (one randomized control trial and four retrospective cohort) where the effects of continuous hypertonic saline were studied in patients with acute ischemic infarcts. Collectively, there is a lack of substantial evidence supporting its use. Also, this review emphasizes significant study flaws that make the conclusions largely nongeneralizable. Although the reported studies demonstrate improvement in control of intracranial pressure, there are no significant differences in neurological or functional outcomes or overall mortality.

Keyword

Cerebral edema; Hypertonic saline; Ischemic strokes; Mortality; Neurologic outcomes

Figure

• 

  Fig. 1. Study flowchart. TBI, traumatic brain injury.

Reference

1. Chen CH, Toung TJ, Sapirstein A, Bhardwaj A. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. J Cereb Blood Flow Metab. 2006; 26:951–8.

2. Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care. 2004; 1:219–33.

3. Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus. 2007; 22:E1.

4. Toung TJ, Hurn PD, Traystman RJ, Bhardwaj A. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med. 2002; 30:644–9.

5. Zeng HK, Wang QS, Deng YY, Jiang WQ, Fang M, Chen CB, et al. A comparative study on the efficacy of 10% hypertonic saline and equal volume of 20% mannitol in the treatment of experimentally induced cerebral edema in adult rats. BMC Neurosci. 2010; 11:153.

6. Bhardwaj A, Harukuni I, Murphy SJ, Alkayed NJ, Crain BJ, Koehler RC, et al. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke. 2000; 31:1694–701.

7. Papangelou A, Toung TJ, Gottschalk A, Mirski MA, Koehler RC. Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke. Neurocrit Care. 2013; 18:106–14.

8. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1.

9. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016; 5:210.

10. Qureshi AI, Suarez JI, Bhardwaj A, Mirski M, Schnitzer MS, Hanley DF, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998; 26:440–6.

11. Larive LL, Rhoney DH, Parker D Jr, Coplin WM, Carhuapoma JR. Introducing hypertonic saline for cerebral edema: an academic center experience. Neurocrit Care. 2004; 1:435–40.

12. Hauer EM, Stark D, Staykov D, Steigleder T, Schwab S, Bardutzky J. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med. 2011; 39:1766–72.

13. Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup J. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients: a randomized clinical trial [ISRCTN62699180]. Crit Care. 2005; 9:R530–40.

14. Erdman MJ, Riha H, Bode L, Chang JJ, Jones GM. Predictors of acute kidney injury in neurocritical care patients receiving continuous hypertonic saline. Neurohospitalist. 2017; 7:9–14.

15. Kimberly WT, Sheth KN. Approach to severe hemispheric stroke. Neurology. 2011; 76(7 Suppl 2):S50–6.

16. Forsyth LL, Liu-DeRyke X, Parker D Jr, Rhoney DH. Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury. Pharmacotherapy. 2008; 28:469–84.

17. Cook AM, Morgan Jones G, Hawryluk GW, Mailloux P, McLaughlin D, Papangelou A, et al. Guidelines for the acute treatment of cerebral edema in neurocritical care patients. Neurocrit Care. 2020; 32:647–66.

18. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002; 33:136–40.